About this trial
The goal of this pilot, feasibility study is to evaluate the feasibility and preliminary impact of a finance-specific psycho-oncology intervention, as well as to explore perceptions of and experiences with this financial psycho-oncology intervention for patients with cancer experiencing financial hardship. The main questions it aims to answer are:
1. Is this financial psycho-oncology intervention feasible, acceptable, and appropriate for patients with cancer experiencing financial hardship? 2. How can we refine the financial psycho-oncology intervention to best address financial distress for patients with cancer experiencing financial hardship?
Patients enrolled in the intervention will receive 2, 60-minute long, finance-specific psycho-oncology sessions per month over the course of 3 months, for a total of 6 sessions over the course of the intervention. Patients will complete surveys during intervention enrollment and after intervention completion to assess secondary outcomes of financial hardship, psychological distress, stress, and anxiety. Individuals who consent to the financial psycho-oncology intervention will also be invited to participate in a 30-minute semi-structured interview to explore their perceptions of and experiences with the financial psycho-oncology intervention, including concepts of participation and engagement, relevance and acceptability, content and understanding, logistics and practicality, and potential impact.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patients with cancer receiving treatment at the UAB Medical Oncology and/or UAB Supportive Care clinics
Disqualifiers
non-English speakers
patients with non-melanoma skin cancers
patients with dementia/cognitive impairments
Trial design
Single group
Treatments tested in this trial
Financial psycho-oncology intervention
BehavioralProgram which integrates emotional support, coping strategies, and financial psychoeducation to enhance patients' capacity to cope with both their emotional and financial burdens due to cancer.
Treatment groups
Trial outcomes
Primary outcomes
Recruitment as a measure of feasibility
50% of contacted patients consenting to participate
Retention as a measure of feasibility
70% of consenting patients completing the program per protocol
Completion as a measure of feasibility
\<15% missing survey data
Secondary outcomes
Change in Financial hardship
as measured by COmprehensive Score for financial Toxicity (COST)
Change in Psychological distress
as measured by National Comprehensive Cancer Network Distress Thermometer and Problem List
Change in Perceived stress
as measured by Perceived Stress Scale (PSS-10)
Change in Anxiety
as measured by PROMIS Emotional Distress - Anxiety - Short Form 4
Sponsors and contacts
Click on the lead sponsor to view all of their trials.